Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports |
| |
| Authors: | Dr Dharam V Ablashi Paul H Levine Caterina De Vinci James E Whitman Jr Giancarlo Pizza Dimitri Viza |
| |
| Institution: | (1) Advanced Biotechnologies Inc, 9108 Guilford Road, 21046 Columbia, MD, USA;(2) Department of Microbiology & Immunology, Georgetown University School of Medicine, 20007 Washington, DC, USA;(3) Viral Epidemiology Branch, National Cancer Institute, 20892 Rockville, MD, USA;(4) Immunotherapy Unit 1st Division of Urology, St. Orsola-Malpighi Hospital, Bologna, Italy;(5) URA 1294 CNRS Laboratoire d’Immunobiologie, Faculté de Médecine des Saints-Pères, Paris, France |
| |
| Abstract: | Specific Human Herpes virus-6 (HHV-6) transfer factor (TF) preparation, administered to two chronic fatigue syndrome patients,
inhibited the HHV-6 infection. Prior to treatment, both patients exhibited an activated HHV-6 infection. TF treatment significantly
improved the clinical manifestations of CFS in one patient who resumed normal duties within weeks, whereas no clinical improvement
was observed in the second patient. It is concluded that HHV-6 specific TF may be of significant value in controlling HHV-6
infection and related illnesses. |
| |
| Keywords: | chronic fatigue syndrome human herpes virus type 6 transfer factor |
| 本文献已被 SpringerLink 等数据库收录！ |
|
